Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Dosage Regimen: Individualization
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Prescription, Nonprescription and Orphan Drugs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 13, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Rena M Conti1, Richard G Frank1, Jonathan Gruber1
1From the Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston (R.M.C.); the USC-Brookings Schaeffer Initiative on Health Policy, Brookings Institution, Washington, DC (R.G.F.); and the Department of Economics, Massachusetts Institute of Technology, Cambridge (J.G.).
No abstract available in PubMed .